Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 3;6(1):e2250126.
doi: 10.1001/jamanetworkopen.2022.50126.

Incidence of Dementia Following Hospitalization With Infection Among Adults in the Atherosclerosis Risk in Communities (ARIC) Study Cohort

Affiliations

Incidence of Dementia Following Hospitalization With Infection Among Adults in the Atherosclerosis Risk in Communities (ARIC) Study Cohort

Bruno Bohn et al. JAMA Netw Open. .

Abstract

Importance: Factors associated with the risk of dementia remain to be fully understood. Systemic infections are hypothesized to be such factors and may be targets for prevention and screening.

Objective: To investigate the association between hospitalization with infection and incident dementia.

Design, setting, and participants: Data from the community-based Atherosclerosis Risk in Communities (ARIC) study, a prospective cohort study, were used. Enrollment occurred at 4 research centers in the US, initiated in 1987 to 1989. The present study includes data up to 2019, for 32 years of follow-up. Data analysis was performed from April 2021 to June 2022.

Exposures: Hospitalizations with infections were identified via medical record review for selected International Classification of Diseases, Ninth Revision (ICD-9) and International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) codes, from baseline until administrative censoring or dementia diagnosis. Participants were considered unexposed until first hospitalization with infection and exposed thereafter. Selected infection subtypes were also considered.

Main outcomes and measures: Incident dementia and time-to-event data were identified through surveillance of ICD-9 and ICD-10 hospitalization and death certificate codes, in-person assessments, and telephone interviews. A sensitivity analysis was conducted excluding cases occurring within 3 years or beyond 20 years from exposure. Data were collected before study hypothesis formulation.

Results: Of the 15 792 ARIC study participants, an analytical cohort of 15 688 participants who were dementia free at baseline and of Black or White race were selected (8658 female [55.2%]; 4210 Black [26.8%]; mean [SD] baseline age, 54.7 [5.8] years). Hospitalization with infection occurred among 5999 participants (38.2%). Dementia was ascertained in 2975 participants (19.0%), at a median (IQR) of 25.1 (22.2-29.1) years after baseline. Dementia rates were 23.6 events per 1000 person-years (95% CI, 22.3-25.0 events per 1000 person-years) among the exposed and 5.7 events per 1000 person-years (95% CI, 5.4-6.0 events per 1000 person-years) among the unexposed. Patients hospitalized with infection were 2.02 (95% CI, 1.88-2.18; P < .001) and 1.70 (95% CI, 1.55-1.86; P < .001) times more likely to experience incident dementia according to unadjusted and fully adjusted Cox proportional hazards models compared with individuals who were unexposed. When excluding individuals who developed dementia less than 3 years or more than 20 years from baseline or the infection event, the adjusted hazard ratio was 5.77 (95% CI, 4.92-6.76; P < .001). Rates of dementia were significantly higher among those hospitalized with respiratory, urinary tract, skin, blood and circulatory system, or hospital acquired infections. Multiplicative and additive interactions were observed by age and APOE-ε genotype.

Conclusions and relevance: Higher rates of dementia were observed among participants who experienced hospitalization with infection. These findings support the hypothesis that infections are factors associated with higher risk of dementias.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Lutsey reported receiving grants from National Institutes of Health (NIH) during the conduct of the study. Dr Brown reported receiving grants from NIH during the conduct of the study and receiving grant funding from Medtronic to analyze intraoperative time series cardiac surgery data; that work is not related to the current manuscript. Dr Matsushita reported receiving grants from NIH during the conduct of the study. Dr Demmer reported receiving grants from NIH during the conduct of the study. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Survival Plots of Incident Dementia and Any Incident Infection With Hospitalization, the Atherosclerosis Risk in Communities Study, 1987-2019
In both panels, participants censored at loss to follow-up, death, or incident dementia. In panel B only (International Classification of Diseases, Ninth Revision or Tenth Revision positions 1-5), participants also were censored at infection with hospitalization occurrence.
Figure 2.
Figure 2.. Unadjusted Association Between Any Hospitalization With Infection and Incident Dementia
Data are shown for diagnoses with International Classification of Diseases (ICD), Ninth Revision or Tenth Revision positions 1-5 within substrata of age at baseline (median age, 54.45 years), APOE-ε4 genotype, previous stroke or transient ischemic attack (TIA), and sex in the multiplicative (A) and additive (B) scales. HR indicates hazard ratio.

Similar articles

Cited by

References

    1. World Health Organization . Towards a Dementia-Inclusive Society: WHO Toolkit for Dementia-Friendly Initiatives (DFIs). World Health Organization; 2021.
    1. World Health Organization . Global Action Plan on the Public Health Response to Dementia 2017-2025. World Health Organization; 2021.
    1. Shi Y, Holtzman DM. Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight. Nat Rev Immunol. 2018;18(12):759-772. doi:10.1038/s41577-018-0051-1 - DOI - PMC - PubMed
    1. Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurol. 2011;10(9):819-828. doi:10.1016/S1474-4422(11)70072-2 - DOI - PMC - PubMed
    1. Wang D, Zhang X, Du H. Inflammatory bowel disease: a potential pathogenic factor of Alzheimer’s disease. Prog Neuropsychopharmacol Biol Psychiatry. 2022;119:110610. doi:10.1016/j.pnpbp.2022.110610 - DOI - PubMed

Publication types